相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long Noncoding RNA LBCS Inhibits Self-Renewal and Chemoresistance of Bladder Cancer Stem Cells through Epigenetic Silencing of SOX2
Xu Chen et al.
CLINICAL CANCER RESEARCH (2019)
Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide
Sang-Soo Kim et al.
NUCLEIC ACIDS RESEARCH (2018)
Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression
Chunming Jiang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling
Rui Su et al.
CELL (2018)
ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation
Yuan He et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Role of N6-methyladenosine modification in cancer
Xiaolan Deng et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2018)
Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response
Sabine Hombach-Klonisch et al.
PHARMACOLOGY & THERAPEUTICS (2018)
m6A RNA modification controls autophagy through upregulating ULK1 protein abundance
Shouheng Jin et al.
CELL RESEARCH (2018)
SOX2, a sternness gene, induces progression of NSCLC A549 cells toward anchorage-independent growth and chemoresistance to vinblastine
Chungyoul Choe et al.
ONCOTARGETS AND THERAPY (2018)
Long noncoding RNA AC003092.1 promotes temozolomide chemosensitivity through miR-195/TFPI-2 signaling modulation in glioblastoma
Ningbo Xu et al.
CELL DEATH & DISEASE (2018)
Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells
Huijun Zeng et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Sox2 inhibits Wnt-β-catenin signaling and metastatic potency of cisplatin-resistant lung adenocarcinoma cells
Jinxi He et al.
MOLECULAR MEDICINE REPORTS (2017)
LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells
H. Xiong et al.
ONCOGENE (2017)
Long Non-Coding RNA MALAT1 Decreases the Sensitivity of Resistant Glioblastoma Cell Lines to Temozolomide
Hongwei Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Roles of RNA methylation by means of N6-methyladenosine (m6A) in human cancers
Siwei Wang et al.
CANCER LETTERS (2017)
The 2017 World Health Organization classification of tumors of the pituitary gland: a summary
M. Beatriz S. Lopes
ACTA NEUROPATHOLOGICA (2017)
MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling Pathway
Satyendra C. Tripathi et al.
CANCER RESEARCH (2017)
Dynamic RNA Modifications in Gene Expression Regulation
Ian A. Roundtree et al.
CELL (2017)
m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program
Sicong Zhang et al.
CANCER CELL (2017)
Temozolomide in the Era of Precision Medicine
Anish Thomas et al.
CANCER RESEARCH (2017)
DNA repair mechanisms and their clinical impact in glioblastoma
Helene Erasimus et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2016)
Local regulation of gene expression by lncRNA promoters, transcription and splicing
Jesse M. Engreitz et al.
NATURE (2016)
Unique features of long non-coding RNA biogenesis and function
Jeffrey J. Quinn et al.
NATURE REVIEWS GENETICS (2016)
NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer
A. R. Ozes et al.
ONCOGENE (2016)
TGF-β induces SOX2 expression in a time-dependent manner in human melanoma cells
Kasia Weina et al.
PIGMENT CELL & MELANOMA RESEARCH (2016)
Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines
Yanting Liu et al.
ONCOTARGET (2016)
Targeting SOX2 as a Therapeutic Strategy in Glioblastoma
Laura Garros-Regulez et al.
FRONTIERS IN ONCOLOGY (2016)
Temozolomide resistance in glioblastoma multiforme
Sang Y. Lee
GENES & DISEASES (2016)
MGMT Promoter Methylation Is a Strong Prognostic Biomarker for Benefit from Dose-Intensified Temozolomide Rechallenge in Progressive Glioblastoma: The DIRECTOR Trial
Michael Weller et al.
CLINICAL CANCER RESEARCH (2015)
Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide
Khaled Messaoudi et al.
DRUG DISCOVERY TODAY (2015)
The emerging role of IncRNAs in cancer
Maite Huarte
NATURE MEDICINE (2015)
Long non-coding RNA SOX2OT: expression signature, splicing patterns, and emerging roles in pluripotency and tumorigenesis
Alireza Shahryari et al.
FRONTIERS IN GENETICS (2015)
A long noncoding RNA Sox2ot regulates lung cancer cell proliferation and is a prognostic indicator of poor survival
Zhibo Hou et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Internal mRNA Methylation Finally Finds Functions
Timothy W. Nilsen
SCIENCE (2014)
Transient Activation of Autophagy via Sox2-Mediated Suppression of mTOR Is an Important Early Step in Reprogramming to Pluripotency
Shuo Wang et al.
CELL STEM CELL (2013)
Sox proteins: regulators of cell fate specification and differentiation
Yusuke Kamachi et al.
DEVELOPMENT (2013)
Transcriptome-wide mapping of N6-methyladenosine by m6A-seq based on immunocapturing and massively parallel sequencing
Dan Dominissini et al.
NATURE PROTOCOLS (2013)
Dry Age-Related Macular Degeneration: Mechanisms, Therapeutic Targets, and Imaging
Catherine Bowes Rickman et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq
Dan Dominissini et al.
NATURE (2012)
MOLECULAR MEDICINE Defence against oxidative damage
Fernando Cruz-Guilloty et al.
NATURE (2011)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
